Research datakeyboard_double_arrow_right Dataset , Bioentity 11 Jul 2011Publisher:Worldwide Protein Data BankFunded by:NIH | Drug Resistance in HCV NS..., NIH | Technical Assistance to S...

Authors: C. A. Schiffer; K. P. Romano;

doi: 10.2210/pdb3su3/pdb

Crystal structure of NS3/4A protease in complex with vaniprevir

- Summary
- Related research
  (4)
- Metrics

tips_and_updates
Recommended

No summary information available

4 Research products, page 1 of 1

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Crystal structure of NS3/4A protease in complex with vaniprevir

Crystal structure of NS3/4A protease in complex with vaniprevir

4 Research products, page 1 of 1

The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors

The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors

Structural Similarity of SARS-CoV2 Mpro and HCV NS3/4A Proteases Suggests New Approaches for Identifying Existing Drugs Useful as COVID-19 Therapeutics

Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors